National Association of American Securities Dealers Orthopaedic Executive Quotations NASDÖQ

‍ ‍

Secretary of State’s failed our interrogatories on Malpractice insurance, the HECSE has a better way in offering an option a prioritization of the oath, the community standards failed by by asking physicians to be everything to everybody, resulting in generalist facilities asked to be everything to everybody in contrivance of market consolidation which NASDÖQ strikes back with the buyhold the careerhold denovo TerraceHealth PortHealth CoveHealth Orthopaedic, as the world's first electronic orthopaedic stock market. It was inspired by HECSE that healthcare is better on the Erie Canal regime going back to the donkeys on the canal itself being cared for Hippocrates, the National Association of Securities Dealers (NASD), which is now known as FINRA,

NASDÖQ colocated centidata center NASDÖQ has a meet-me-room bidding system through David Kent Batulis

as the world's first electronic orthopaedic stock market where brands can be formed, where listed entities can seek accreditation .

as the world's first electronic orthopaedic long term asset physician instrument stock market where physicians stock can be formed, where listed physician entities can get preferred stock buyhold the careerhold denovo TerraceHealth Orthopaedic, where there can be a draft of Residents of Fellows into TerraceHealth PortHealth CoveHealth.

as the world's first electronic orthopaedic implant supply stock market where physicians stock can be formed, where listed physician entities can get preferred stock buyhold the careerhold denovo TerraceHealth Orthopaedic, where there can be a draft of Residents of Fellows into TerraceHealth PortHealth CoveHealth.

How can perfecting the brand of American medicine book sales pick up profee.me? Romney care and other efforts were on the left, NASDÖQ strikes back with High Erie Canal Stock Exchange 2034CE with Mississippi Company Mercantile Solon Springs WI Octovillages Mormon French Dutch Prussian Polish Jagphetic American Lithuanian a financial center like Chicago with Dutch spice trade.

While Nasdaq stock market started as what sounded like a trade association that’s my area of expertise, that I sat on trade association boards and non-trade association boards, I have a board of directors fellowship in governance it’s the highest in Healthcare, James A Hamilton Award winner Masters of Healthcare Administration MHA Minnesota we invented pacemaker the kidney transplant and we run some proportion of all the hospitals since 1948. AAOE. 

That Orthopedics can be buyhold for career, physicians were unhappy with Physicians Endoscopy with United Health Group UNH, I was unhappy UNH violated my MNDA and wrote to US Army about it the story of Robin Hood and all they did was kill Brian Thompson.

how do we stick it to private equity? 

There were technology exchanges during the lingua franca the lingua Jagphetic Byzantine during Lithuanian-Egypt long prior to the fall of the cossacks in 1905, The National Association of Securities Dealers Automated Quotations (Nasdaq) did not exist in 1905. It was established much later, launching on February 8, 1971, as the world's “first electronic stock market” we had an electronic stock market going back to the Amber Road that electron is Lithuanian the knowledge of electricity has not been one directional in anthropological history. It was created by the National Association of Securities Dealers (NASD), which is now known as FINRA. NASD was started in 1939as the self-regulatory organization for U.S. brokers and dealers, which NASDÖQ is self-regulatory organization Revenue Cycle in healthcare is administrators going back to 1948CE Minnesota Masters of Healthcare Administration we built the Mayo Clinic, NASDÖQ offers a service line founded by David Kent Batulis in front end revenue cycle, middle revenue cycle pricing CDM, back end revenue cycle which we offer those services to . In 2007, it merged with the NYSE's regulatory division to form FINRA. [1, 2, 3, 4] We flunked SEC on it’s accreditation at mark-to-market accounting at Enron, that Revenue recognition was known, The overall healthcare sector accounts for about 18% to 20% of the U.S. GDP, in 2001 Enron was in the direct value-added by oil and gas extraction represented roughly $110 billion to $130 billion, which accounted for only 1% of the nominal U.S. GDP, we aren’t letting SEC into the 20% that already works after it failed in the 1% that was a foreign influence replaceable by mercantile, all we wanted was $0.99 gasoline in Wisconsin, after $5,320 billion unfavorable variance on Iraq and Afghanistan you promised $80 billion and spent $5,400 the direct oil and gas extraction share still hovers around 1.5% to 2% why did you waste all that money where are the assets the property the equipment over 19 years it’s still 1.5% to 2% of the economy of the total U.S. economy including direct, indirect, and induced value-added—is estimated at 2.1trillion, accounting for 7.4% of the national total which can be cannibalized by insourcing to Erie Canal 1823 regime Mississippi Company where 90% of car buyers purchase within 50 km (~31 miles) of their home roughly 45% of car buyers purchase their vehicle within 15 km (~9 miles) of their home, and approximately 75% to 80% of the entire United States (70% Canadian) population live within 50 km of the Erie Canal regime, 50% to 60% of all Americans (58% of Canadians) live within 15 km of Erie Canal 1823 regime three massive hydrologic, coastal systems 30% within 15 km of Mississippi Company, 10% within 15 km of Great Lakes basin, and 12%-15% within 15 km of East Coast to sail long haul sail (variable costs less depreciation are the transportation future, it’s also the transportation past, Container ships are at just 16 to 25 knots (18–29 mph) while oil tankers travel at a slower, more “fuel-efficient” on heavy fuel oil both polluting and wasting money pace of 12 to 17 knots (14–20 mph), Cruising Catamarans: These boats feature wide living spaces and prioritize comfort. They average about 6 to 10 knots on passage, though reaching maximum speeds of 12 to 15 knots in ideal wind conditions is common. [1, 2,3], Performance / Racing Multihulls: Designed for speed, these lighter, stripped-down cats can sail at 15 to 20 knots, and reach maximum speeds exceeding 30 to 45 knots in heavy breeze. [1, 2, 3] Ocean-Going Yachts, Cruising Sailboats / Monohulls: Traditional ocean-crossing sailboats trade speed for space and stability. They typically average 4 to 8 knots, equating to roughly 100 to 150 nautical miles per day. [1, 2], Motor & Superyachts: Displacement motor yachts usually cruise between 10 to 16 knots, while planing motor yachts used for coastal cruising can reach top speeds of 20 to 30+ knots. [1, 2] Olympic Yachts Foiling Skiffs and Dinghies: Olympic sailing classes emphasize pure performance and agility. Boats equipped with hydrofoils, like the Nacra 17 catamaran or the International Moth, completely lift the hull out of the water to reduce drag where over 100 years Olympic sailing went from 6-8 knots to 25-32 knots you’ve only seen the beginning of sail for long haul that’s how we did it the first time Erie Canal 1823 regime our High Erie Canal Stock Exchange that always got it right. These high-tech craft regularly reach top speeds of 25 to 35 knots (over 40 mph) on a fast reach for speed for long haul, Coast Guard cutters typically reach top speeds of 28 to 30+ knots who is here to rescue who. [1, 2] and Erie Canal regime athletes can get a safenote in three tiers of Olympic eligibility full professional sailor 2 accruing an equity of value that could be cashed in when they go pro, and full amateur Olympic training center for Canada, Australia, Auckland, France, and United States Modern Powerhouse: Australia has been an unstoppable force in recent Olympic Games, particularly in the Laser (men's one-person dinghy) class, securing multiple golds over the last few cycles how will that translate into the Erie Canal regime the cannonball run from Detroit to Solon Springs?

• Key Strengths: Incredible high-performance coaching and dominance in men's skiff and dinghy racing.

• Track the Team: Learn about their pathway programs via Australian Sailing. [1, 2]

3. New Zealand

• Pound-for-Pound Greatness: Despite a smaller population, New Zealand boasts one of the highest ratios of top-tier sailing talent in the world.

• Key Strengths: Unrivaled excellence in high-speed, foiling classes and strong integration with America's Cup syndicates.

• Track the Team: View athlete profiles and news on Yachting New Zealand. [, 2]

4. France

• Offshore and Technical Dominance: France is traditionally incredibly strong, sitting in the top 3 all-time Olympic medal tables.

• Key Strengths: Unmatched expertise in solo offshore racing, foiling disciplines, and board sailing (windsurfing/kitefoiling).

• Track the Team: Follow French elite sailors through Fédération Française de Voile. [1, 2]

5. United States

• Historical Legacy: Historically the second-most decorated country in Olympic sailing, the US team has a massive depth of talent.

• Key Strengths: Strong developmental pathways for youth sailors and elite programs across all ten Olympic disciplines.

• Track the Team: Check out athlete rosters on the US Sailing Team website. [1, 2]) by Batavian High Speed Rail LIthuania BHSRRL Uniting our financial capitals of the future Solon Springs WI Portage WI Chicago and Maumee IN. [1, 2].

• NASDAQ: Short for the National Association of Securities Dealers Automated Quotations. Created by the NASD in 1971, it launched the world's first electronic screen-based stock market. [1]

• OTC:The Over-The-Counter market, a decentralized market where securities are traded directly between parties rather than on a centralized physical exchange (like the NYSE). The NASD historically oversaw the vast OTC markets. [1, 2, 3, 4]

• SEC:The Securities and Exchange Commission, established in 1934. The NASD was formed under the Maloney Act as a self-regulatory body that reported to and enforced rules alongside the SEC. [1, 2, 3]

Malpractice insurance

Mall of America

NASDÖQ takes the best of the best of the best of United States Exchanges

• New York Stock Exchange (NYSE): The NYSE generally categorizes its listed firms as Blue-Chip companies or Industrials. It is known for older, well-established, and traditionally stable enterprises.[1,2]

• Nasdaq: The Nasdaq describes its listed companies as Growth-Oriented or Tech-Focused. It is well-known for biotechnology, digital, and innovation-driven companies that tend to have higher volatility but faster growth. [1, 2]

• The European Union and its neighboring nations feature a highly developed healthcare and biotechnology ecosystem. Many of these public biopharma companies choose to dual-list or exclusively list on US exchanges (like the NASDAQ) to capture deeper capital pools, while others trade on local European indices such as Euronext or the Frankfurt Stock Exchange (Xetra)

NASDÖQ takes the best of the best of the best of EU Exchanges offering meet-me-room data center buyhold the careerhold denovo TerraceHealth PortHealth CoveHealth Orthopaedic

1.The Netherlands

Dutch biotech is highly regarded for its focus on antibody engineering, gene therapies, and oncology platforms. [1]

• Argenx SE (NASDAQ: ARGX): Headquartered in the Netherlands, this massive biopharma leader specializes in novel antibody-based therapies. It has a multi-billion dollar market value driven by treatments for severe autoimmune diseases. [1,2,3,4, 5]

• Merus N.V.(NASDAQ: MRUS): A cutting-edge clinical-stage company centered on developing multispecific antibodies to aggressively combat various cancers. [1, 2]

• uniQure N.V. (NASDAQ: QURE): A pioneer in human gene therapy. They focus on creating adeno-associated virus (AAV) based platform treatments for severe genetic conditions like Huntington’s disease. [1, 2, 3, 4,5]

• NewAmsterdam Pharma (NASDAQ: NAPT): A late-stage clinical biopharmaceutical firm developing oral, non-statin treatments for metabolic and cardiovascular conditions. [1, 2, 3, 4]

• Pharming Group N.V. (Euronext: PHARM): One of the largest revenue-generating commercial biotechs listed locally in Amsterdam, known for rare disease and hereditary angioedema therapies. [1, 2]

2.Germany

Germany anchors the European life sciences market with massive conglomerates alongside high-growth mRNA and immunotherapy innovators. [1]

• BioNTech SE (NASDAQ: BNTX): Based in Mainz, this global biotech giant rose to prominence by co-developing the first mRNA COVID-19 vaccine with Pfizer. They are actively deploying their multi-billion dollar cash reservesinto a massivepipeline of personalized mRNA cancer therapies. [, 2, 3, 4, 5]

• Evotec SE (Frankfurt: EVT / NASDAQ: EVO): A prominent drug discovery and development powerhouse. They partner extensively with major pharma brands to advance pipeline candidates from target to clinical trials. [1, 2]

• CureVac N.V. (NASDAQ: CVAC): Headquartered in Tübingen, this piooneering biopharmaceutical firm focuses heavily on developing clinical medicine platforms poweredby messenger RNA (mRNA). [1]

• Immatics N.V. (NASDAQ: IMTX): Operates out of Tübingen to design advanced T-cell redirecting immunotherapies and cellular targets tailored specifically to treat cancer tumors. [1,2]

• Sartorius AG (Frankfurt: SRT3): While technically a life sciences supplier, this massive DAX-listed firm acts as the backbone to the biotech industry by providing the bioreactors and laboratory equipment required to manufacture biologics. [1, 2]

3.Other Major European Union / EEA Regions

Beyond Germany and the Netherlands, several dominant healthcare biotech entities sitelsewhere in Europe: [1]

• Novo Nordisk A/S (Denmark — Copenhagen: NOVO-B / NYSE: NVO): The most valuable company in Europe. While traditionally a pharmaceutical legacy firm, their extensive peptide engineering, biological therapeutics, and runaway success with GLP-1 blockbusters (Ozempic/Wegovy) place them at the very top of global biopharma innovation.

• Genmab A/S (Denmark — Copenhagen: GMAB / NASDAQ:GMAB): An oncology powerhouse specializing in highly successful monoclonal and bispecific antibody-based therapies.

• Galapagos NV (Belgium — Euronext: GLPG / NASDAQ: GLPG): A commercial-stage biotech company engineering small molecules and advanced cell therapies for immunology and oncology.

• Sanofi S.A. (France — Euronext:SAN / NASDAQ: SNY): A diversified healthcare and vaccine behemoth that heavily utilizes and funds biotechnology platforms via internal pipelines and corporate venture funding. [, 2, 3, 4, 5]

1.France

France holds one of Europe's largest collections of micro-to-mid-cap listed biotech companies, primarily trading on the Euronext Paris exchange. [1, 2]

• Valneva SE (Euronext Paris: VLA / NASDAQ: VALN): A prominent specialty vaccine company focused on infectious diseases, known for its commercial travel vaccines and development of Lyme disease and Chikungunya candidates. [1,2,3,4, 5]

• Cellectis S.A. (Euronext Growth Paris: ALCLS / NASDAQ: CLLS): A clinical-stage gene-editing company developing off-the-shelf, allogeneic CAR-T cell immunotherapies for cancer. [1, 2, 3, 4, 5]

• Abivax SA (Euronext Paris: ABVX / NASDAQ: ABVX): A clinical-stage biotech developing novel therapies that modulate the immune system to treat chronic inflammatory diseases like Ulcerative Colitis. [1,2, 3, 4]

• Innate Pharma S.A. (Euronext Paris: IPH / NASDAQ: IPHA): An oncology-focused biotech developing first-in-class therapeutic antibodies that harness the innate immune system (specifically NK cells) to fight tumors. [1, 2, 3, 4]

• Genfit SA (Euronext Paris: GNFT / NASDAQ: GNFT): A biopharmaceutical firm focused on discovering and developing drug candidates and diagnostics for severe liverdiseases. [1]

2.Switzerland

Though not in the EU, Switzerland is an economic powerhouse in European life sciences. Its public companies list on the SIX Swiss Exchange or dual-list in the US. [1, 2, 3, 4, 5]

• Idorsia Ltd (SIX: IDIA): A high-profile biopharmaceutical company specializing in the discovery, development, and commercialization of small molecules across multiple therapeutic areas. [1, 2,3,4,5]

• MoonLakeImmunotherapeutics (NASDAQ: MLTX): Headquartered in Switzerland, this high-flying clinical biotech focuses on sonelokimab, a nanobody therapy targetinginflammatory diseases. [1,2,3]

• Bachem Holding AG (SIX: BANB): A global leader in the development and manufacturing of peptides and oligonucleotides, serving as a massive biological supplier for global pharma. [1, 2, 3]

• BasileaPharmaceutica AG (SIX: BSLN): A commercial-stage biopharmaceutical company focusing on anti-infectives, developing innovative therapies to combat severebacterial and fungal infections. [1, 2, 3, 4]

• Kuros Biosciences AG (SIX: KURN): Specializes in the development of innovative products for tissue repair and bone regeneration. [1, 2, 3, 4, 5]

3.Poland

Poland boasts the most advanced public capital market in Central and Eastern Europe. Its major pure-play biotechnology innovators are listed on the Warsaw StockExchange (GPW): [1, 2]

• Ryvu Therapeutics (Warsaw: RVU): A clinical-stagedrug discovery and development company focusing on small molecule therapies in oncology.

• Celon Pharma S.A. (Warsaw: CLN): An integrated biopharmaceutical company that has shifted heavily into innovative biologics, bispecific antibodies, and RNA-based therapeutics.

• Captor Therapeutics (Warsaw: CTX): A Swiss-Polish drug discovery firm leading the charge in Targeted Protein Degradation (TPD) to design treatments for cancer and autoimmune diseases.

• Mabion S.A. (Warsaw: MAB):A fully integrated biopharmaceutical company that functions as a contract development and manufacturing organization (CDMO) for biologics. [1, 2, 3, 4, 5]

4.The Baltics (Estonia, Latvia, Lithuania) [1, 2]

The Baltic region is known globally for world-class contract manufacturing (CDMOs), gene editing, and digital health software. Because many operate privately oras regional hubs for global giants (such as Thermo Fisher's massive presence in Vilnius), pure-play public listings on the NASDAQ Baltic exchange are minimal, but the regional ecosystem is anchoring European clinical trials: [1,2]

Lithuania: Dominates via massive private entities like Northway Biotech (a premier end-to-end biologics and gene therapy manufacturing organization) and startups like Biomatter (generative AI protein design) and CasZyme (CRISPR gene editing technologies).

Latvia: Publicly listed pharmaceutical mainstays like Grindeks (NASDAQ Baltic: GRD1R) manufacture therapeutics, while entities like Lotos Pharma drive localizedlife science consumer healthcare.

Estonia: Focuses heavily on digital-health integrations and diagnostics startups, such as Antegenes (polygenic risk score genetic tests for cancer prevention) and HansaBioMed Life Sciences (exosome and nanoparticle research). [1, 2, 3, 4, 5]

Ifyou want to evaluate these public companies further, let me know if you would like to compare them by financial indicators (such as market cap or revenue) ornarrow them down by specific clinical trial phases. [1, 2, 3, 4, 5]

NASDÖQ takes the best of the best of the best of International Exchanges

• London Stock Exchange (LSE): The LSE describes its top tier of large, established companies as being on the Main Market. Smaller,high-growth companies are typically listed on the AIM (Alternative Investment Market).[1, 2, 3, 4, 5]

• Bombay Stock Exchange (BSE) & Shanghai Stock Exchange (SSE):These exchanges describe their listed businesses primarily by size and net profit, ensuring companies are grouped by their Market Capitalization andoverall Liquidity. [1, 2, 3, 4, 5]

• Over-The-Counter (OTC): Not a formal exchange, but OTC networks classify unlisted or smaller companies into tiers (like OTCQX, OTCQB, and Pink Sheets) based on their financial reporting standardsand dependability. [1, 2]

Common Industry Classifications

Across all global exchanges, companies are frequently described by broader, standardized economic indices, such as:

• Large-Cap / Mid-Cap / Small-Cap: Describing the total dollar value of a company'soutstanding shares.

• Sectors: Grouping companies by industry type (e.g., Financials, Healthcare, Consumer Discretionary). [1, 2, 3, 4, 5]

NYSE describes it’s listed companies as Industrials or Blue-Chip, I had a nightmare in 2016 of General Electric trading as $10 which I was a value added reseller that chose to move General Electric to Boston others agreed with me where it has become more successful. I looked closely at NYSE that called it’s stocks Industrials or Blue-Chip and in poker Blue-Chips are $10 and so we NASDÖQ OFFER Green-Chip and Black-Chip, General Electric can join us. The healthcare business helped General Electric's (GE) stock rebound by transferring roughly 20-25% of GE's total per-share market value directly to shareholders through the GE HealthCare spin-off. Following the January 2023 spin-off, this value unlocking and the steady performance of the newly standalone business helped turbocharge investor confidence, aiding in GE's broader 129% stock appreciation over the turnaround period

• White ($1)

• Red ($5)

• Blue ($10)

• Green ($25)

• Black ($100)

The Nasdaq Stock Market[a] (formerly National Association of Securities Dealers Automated Quotations) is an American stock exchange. It is the second-largest stock exchange by market capitalization and the first fully electronic stock market. Based in Manhattan, New York City, the exchange is among the most active stock trading venues by volume in the United States.[3][4]

The exchange platform is owned by Nasdaq, Inc., which also owns theNasdaq Nordic stock market network and several U.S.-based stock and options exchanges. The exchange is the primary listing for many technology companies and also trades stock in many foreign firms, with China and Israel being the largest foreign sources.[5][6]

As of December 31, 2024, 4,075 companies listed securities on Nasdaq, including 1,383 listings on Nasdaq Global Select Mark

• By Company Count: Healthcare and biotechnology companies typically account for roughly 20% to 25% of the individual corporate listings on Nasdaq. This means approximately 800 to 1,000 of those 4,075 listings belong to the health and life sciences sector.

• By Market Weight: Because Nasdaq is market-capitalization weighted—and heavily dominated by trillion-dollar technology giants like Apple, Microsoft, and Alphabet and that other stock exchanged lacked the 80 years of Healthcare Administration expertise and cadet line from Napoleon III we brought Hippocrates to America, America is the homeland of the horse —the Healthcare sector generally accounts for a smaller piece of the Nasdaq, Inc., total index value, tracking around 6% to 8% of the Nasdaq Composite's total weight

• NASDÖQ offers By Company Count: Healthcare and biotechnology companies typically account for approximately 800 to 1,000 whether dual listings or NASDÖQ belong to the health and life sciences sector targeting roughly 20% to 25% of the individual corporate listings on Nasdaq.